Interstitial pneumonia secondary to Hermansky-Pudlak syndrome type 4 treated with different antifibrotic agents

Junko Itano, Yasushi Tanimoto, Goro Kimura, Noboru Hamada, Hisaaki Tanaka, Shinsuke Ninomiya, Kenjiro Kosaki, Nobuaki Miyahara, Yoshinobu Maeda, Katsuyuki Kiura

研究成果: Article査読

抄録

Hermansky-Pudlak syndrome (HPS) is an autosomal recessive hereditary disease that may be complicated by progressive and potentially fatal interstitial pneumonia. We herein report a 64-year-old woman with interstitial pneumonia associated with HPS type 4 whom we treated with nintedanib after pirfenidone proved ineffective. To our knowledge, there have been no previous reports of nintedanib being used to treat a patient with HPS type 4. There is a need for clinical trials of antifibrotic agents, including nintedanib, pirfenidone, and new therapeutic agents with different mechanisms of action in these patients.

本文言語English
ページ(範囲)783-788
ページ数6
ジャーナルInternal Medicine
60
5
DOI
出版ステータスPublished - 2021 3 1

ASJC Scopus subject areas

  • Internal Medicine

フィンガープリント 「Interstitial pneumonia secondary to Hermansky-Pudlak syndrome type 4 treated with different antifibrotic agents」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル